Der Vaart Sandra D Van's Net Worth
$8.73 Million
Who is Der Vaart Sandra D Van?
Der Vaart Sandra D Van has an estimated net worth of $8.73 Million. This is based on reported shares across multiple companies, which include LABORATORY CORP OF AMERICA HOLDINGS, Fortrea Holdings Inc., SEQUENOM INC, and ORCHID CELLMARK INC.
SEC CIK
Der Vaart Sandra D Van's CIK is 0001537208
Past Insider Trading and Trends
2020 was Der Vaart Sandra D Van's most active year for acquiring shares with 8 total transactions. Der Vaart Sandra D Van's most active month to acquire stocks was the month of January. 2021 was Der Vaart Sandra D Van's most active year for disposing of shares, totalling 16 transactions. Der Vaart Sandra D Van's most active month to dispose stocks was the month of January. 2021 saw Der Vaart Sandra D Van paying a total of $763,740.00 for 15,393 shares, this is the most they've acquired in one year. In 2021 Der Vaart Sandra D Van cashed out on 20,930 shares for a total of $3,042,430.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.91
EVP, Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.19% | -2.00K |
$210.83 | -$421,655.24 | 5.64K |
May 14
| |||
Form 4
|
—
|
0
|
$216.67 | -$1,334,242.07 | 7.64K |
Scheduled
|
Mar 27 - Mar 28
| ||
Form 4
| -3.01% | -237.00 |
$226.45 | -$53,668.65 | 7.64K |
Scheduled
|
Feb 13
| ||
Form 4
| +3.10% | 237 |
$227.45 | -$19,788.15 | 7.87K |
Feb 11 - Feb 12
| |||
Form 4
| -3.28% | -259.00 |
$222.06 | -$57,513.54 | 7.64K |
Scheduled
|
Feb 8
| ||
Form 4
| +3.39% | 259 |
$223.71 | -$21,028.74 | 7.9K |
Feb 6 - Feb 7
| |||
Form 4
|
—
|
0
|
$220.83 | -$58,299.35 | 7.64K |
Scheduled
|
Feb 2 - Feb 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| -2.71% | -212.00 |
$240.00 | -$50,880.00 | 7.6K |
Jun 29
| |||
Form 4
| +40.30% | 2.24K |
$224.70 | -$308,063.70 | 7.79K |
Mar 30
| |||
Form 4
| +3.97% | 212 |
$248.13 | -$19,354.14 | 5.55K |
Feb 11 - Feb 13
| |||
Form 4
| -3.94% | -219.00 |
$243.01 | -$53,219.19 | 5.34K |
Scheduled
|
Feb 7
| ||
Form 4
| +4.10% | 219 |
$244.50 | -$19,804.50 | 5.56K |
Feb 4 - Feb 6
| |||
Form 4
|
—
|
0
|
$254.19 | -$60,244.06 | 5.34K |
Scheduled
|
Feb 2 - Feb 3
| ||
Form 4
| -31.66% | -2.45K |
$277.11 | -$678,642.39 | 5.29K |
Scheduled
|
Mar 29
| ||
Form 4
| +46.32% | 2.45K |
$276.42 | -$495,344.64 | 7.74K |
Mar 27 - Mar 28
| |||
Form 4
| -3.77% | -207.00 |
$273.98 | -$56,713.86 | 5.29K |
Scheduled
|
Feb 15
| ||
Form 4
| +3.92% | 207 |
$272.68 | -$20,996.36 | 5.49K |
Feb 11 - Feb 14
| |||
Form 4
|
—
|
0
|
$277.41 | -$83,222.20 | 5.29K |
Scheduled
|
Feb 4 - Feb 7
| ||
Form 4
|
—
|
0
|
$272.18 | -$64,234.84 | 5.29K |
Scheduled
|
Feb 2 - Feb 3
| ||
Form 4
|
—
|
0
|
$190.82 | -$953,640.00 | 5.26K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$175.71 | -$817,650.00 | 5.24K |
Scheduled
|
Jun 7
| ||
Form 4
| -13.42% | -812.00 |
$251.88 | -$204,526.56 | 5.24K |
Scheduled
|
Mar 30
| ||
Form 4
| +36.67% | 1.62K |
$251.58 | -$172,835.46 | 6.05K |
Mar 27
| |||
Form 4
| +4.91% | 207 |
$237.29 | -$86,846.71 | 4.43K |
Scheduled
|
Feb 12 - Feb 16
| ||
Form 4
| +2.63% | 108 |
$224.96 | -$43,191.39 | 4.22K |
Scheduled
|
Feb 4 - Feb 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| -9.71% | -435.00 |
$170.00 | -$73,950.00 | 4.04K |
Scheduled
|
Jul 2
| ||
Form 4
| -16.30% | -872.00 |
$160.33 | -$139,807.76 | 4.48K |
Scheduled
|
Jun 24
| ||
Form 4
| +95.58% | 2.62K |
$131.95 | -$145,936.70 | 5.35K |
Mar 30
| |||
Form 4
| +8.19% | 207 |
$188.07 | -$68,832.50 | 2.74K |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
| +5.55% | 133 |
$182.14 | -$42,620.00 | 2.53K |
Scheduled
|
Feb 7 - Feb 10
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| -50.00% | -2.33K |
$176.75 | -$411,474.00 | 2.33K |
Scheduled
|
Jul 8
| ||
Form 4
| +412.66% | 3.75K |
$154.79 | -$275,835.78 | 4.66K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Fortrea Holdings Inc. (FTRE) Snapshot price: $20.09
President and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.82K |
—
|
—
| 7.82K |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SEQUENOM INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ORCHID CELLMARK INC No price found
Assistant Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |